presbyopia

Visus concludes subject enrolment in presbyopia therapy trial
Visus concludes subject enrolment in presbyopia therapy trial
Clinical Trials Arena
Visus Therapeutics
clinical trials
presbyopia
Brimochol
Flag link:
Novartis drops presbyopia drug acquired with Encore Vision
Novartis drops presbyopia drug acquired with Encore Vision
Pharmaphorum
Novartis
presbyopia
UNR844
Encore VIsion
Flag link:
AbbVie prices first presbyopia drug Vuity at $80 per month
AbbVie prices first presbyopia drug Vuity at $80 per month
Pharmaforum
AbbVie
Vuity
presbyopia
Flag link:
AbbVie claims first FDA okay for presbyopia drug therapy
AbbVie claims first FDA okay for presbyopia drug therapy
Pharmaforum
AbbVie
FDA
presbyopia
AGN-190584
Flag link:
Visus raises $20M ahead of data drop on rival to AbbVie prospect
Visus raises $20M ahead of data drop on rival to AbbVie prospect
Fierce Biotech
Visus Therapeutics
AbbVie
Eyenovia
funding
presbyopia
Flag link:
Allergen builds case for first drug therapy for presbyopia
Allergen builds case for first drug therapy for presbyopia
Pharmaforum
Allergan
presbyopia
AGN-190584
Flag link:
No more squinting at menus? Visus Therapeutics nabs $36M for presbyopia-correcting eye drop
No more squinting at menus? Visus Therapeutics nabs $36M for presbyopia-correcting eye drop
Endpoints
Visus Therapeutics
presbyopia
Brimochol
Flag link:
Former Allergan program posts positive topline PhIII results in farsightedness in an R&D win post-AbbVie merger
Former Allergan program posts positive topline PhIII results in farsightedness in an R&D win post-AbbVie merger
Endpoints
Allergan
AbbVie
presbyopia
clinical trials
AGN-190584
Flag link:
Orasis Pharmaceuticals snags $30M to see its presbyopia treatment through to PhIII
Orasis Pharmaceuticals snags $30M to see its presbyopia treatment through to PhIII
Endpoints
Orasis Pharmaceuticals
presbyopia
Flag link:
Eyedrops Instead of Reading Glasses – Company Begins Ph IIb Trial
Eyedrops Instead of Reading Glasses – Company Begins Ph IIb Trial
CP Wire
Orasis Pharmaceuticals
clinical trials
presbyopia
Flag link: